Текст уведомления здесь

A Russian drug for HIV therapy might soon reach clinical trials phase

The Russian drug for the treatment of HIV infection is approaching the phase of clinical trials, stated Anna Popova, the head of Rospotrebnadzor (the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing), on Wednesday at the VI International Eastern Europe and Central Asia AIDS Conference.
Добавить в закладки
Комментарии

The Central Research Institute of Epidemiology of Rospotrebnadzor is working on the creation of fundamentally new drugs for gene therapy, gene prophylaxis and molecular vaccination against HIV infection: a highly active antiviral drug «Dinavir» has been developed that is approaching the clinical trials phase," said Popova.

Добавить в закладки
Комментарии
Вам понравилась публикация?
Расскажите, что вы думаете, и мы подберем подходящие материалы